282
M. Pokladko et al. / Spectrochimica Acta Part A 73 (2009) 281–285
The reaction mixture was diluted with water; the precipitate was
filtered off, dried and crystallized.
2.1.2. 4-(2-tert-Butylphenoxy)-3-methyl-1-phenyl-1H-
pyrazolo[3,4-b]quinoline
6a
Light yellow needless, 51%, mp. 172–3 ◦C (toluene).
1H NMR (300 MHz, CDCl3, ı ppm): 1.68 (s, 9H, tert-Bu); 2.46 (s,
3H, 3-Me); 6.31 (d, J = 7.9 Hz, 1H); 6.96 (t, J = 7.6 Hz, 1H); 7.04 (t,
J = 7.6 Hz, 1H); 7.28 (t, J = 7.4 Hz, 1H); 7.33 (t, J = 7.5, 1H, 6-H); 7.51
(d, J = 7.8, 1H); 7.54 (t, J = 7.9 Hz, 3,5-H1Ph); 7.72 (t, J = 7.2 Hz, 1H, 7-
H); 7.99 (d, J = 8.4 Hz, 1H, 5-H); 8.17 (d, J = 8.7 Hz, 1H, 8-H); 8.48 (d,
J = 7.9 Hz, 2H, 2,6-H1Ph).
13C NMR (300 MHz, CDCl3, ı ppm): 14.89; 30.13; 35.19; 111.08;
114.8; 118.61; 120.44; 122.86; 123.07; 123.39; 123.89; 125.12;
127.51; 127.74; 129.03; 129.05; 130.89; 137.25; 139.84; 142.14;
150.89; 152.59; 153.27; 157.91.
Anal.cald for C27H25N3O: C 79.58; H 6.18; N 10.31. Found C 79.51;
H 6.12; N 10.03.
2.1.3. 3-Methyl-4-(naphtalen-1-yloxy)-1-phenyl-1H-
pyrazolo[3,4-b]quinoline
6b
Light yellow crystals, 55%, mp. 167 ◦C.
1H NMR (300 MHz, CDCl3, ı ppm): 2.36 (s, 3H, Me); 6.32 (d,
J = 7.7 Hz, 1 H); 7.16 (t, J = 7.9 Hz, 1 H); 7.24–7.33 (m, 2H); 7.55 (t,
J = 8.1 Hz, 3H); 7.65 (t, J = 7.3 Hz, 1H); 7.69 (t, J = 7.4 Hz, 1H); 7.74 (t,
J = 7.6 Hz, 1H); 7.94 (d, J = 8.1 Hz, 1H); 8.04 (d, J = 8.5 Hz, 1H, 5-H);
8.19 (d, J = 8.7 Hz, 1H, 8-H); 8.50 (d, J = 8.0 Hz, 2H, 2,6-H1Ph); 8.67 (d,
J = 8.15 Hz, 1H).
13C NMR (300 MHz, CDCl3, ı ppm): 14.50; 108.33; 111.11; 118.85;
120.33; 121.52; 122.70; 122.88; 124.12; 124.69; 125.12; 125.61;
126.47; 127.87; 128.99; 129.04; 131.12; 134.84; 139.85; 142.23;
150.76; 152.64; 153.67; 155.27.
Anal. calcd. for C27H19 N3O: C 80.78; H 4.77; N 10.46. Found C
80.56; H 4.34; N 10.32.
2.1.4. 4-(Biphenyl-4-yloxy)-3-methyl-1-phenyl-1H-pyrazolo[3,4-
b]quinoline
6c
Yellow needless, 49%, mp. 171–2 ◦C (toluene).
1H NMR (300 MHz, CDCl3, ı ppm): 2.40 (s, 3H, Me); 6.95
(d, J = 8.6 Hz, 2H); 7.23–7.42 (m, 5H); 7.50–7.55 (m, 6H); 7.75 (t,
J = 7.6 Hz, 1H, 7-H); 8.10 (d, J = 8.4 Hz, 1H, 5-H); 8.17 (d, J = 8.7 Hz,
1H, 8-H); 8.47 (d, J = 8.1 Hz, 2H, 2,6-H1Ph).
Fig. 1. Chemical formula of Mol. 1–5.
13C NMR (300 MHz, CDCl3, ı ppm): 14.84; 110.95; 115.83; 118.83;
120.33; 122.99; 124.05; 125.10; 126.77; 127.13; 128.64; 128.77;
128.94; 129.00; 131.06; 136.06; 139.55; 139.80; 140.05; 142.11;
150.72; 152.58; 153.25; 158.71.
of 2 with phenylhydrazine gave 2-(5-methyl-2-phenyl-2H-pyrazol-
3-ylamino)-benzoic acid 3. This acid can be converted to
4-hydroxyderivative 4 by heating it in polyphosphoric acid PPA
or immediately to 4-chloro-3-methyl-1-phenyl-1H-pyrazolo[3,4-
b]quinoline 5 by heating with POCl3. Both 4 and 5 are the
source of many fluorescent and biologically active substances.
The synthetic details of products 2,3,4 and 5 are described
in literature [14]. 4-Chloro-3-methyl-1-phenyl-1H-pyrazolo[3,4-
b]quinoline was transformed into aryloxy derivatives by heating
with hydroxy aromatic compounds ArOH in EtOH/KOH solution.
1H NMR spectra were recorded on Mercury-Vx 300 MHz Varian.
Melting points were measured on Melt-temp apparatus.
Chemicals were purchased from commercial suppliers (Merck
or Aldrich). Solvents were purchased from POCh (Polish Chemical
Company).
Anal. calcd. for C29H21N3O: C 81.48; H 4.95; N 9.83. Found C
81.27; H 4.67; N 9.74.
2.1.5. 4-(Biphenyl-2-yloxy)-3-methyl-1-phenyl-1H-pyrazolo[3,4-
b]quinoline
6d
Light yellow crystals, 56%, mp. 185–7 ◦C (toluene).
1H NMR (300 MHz, CDCl3, ı ppm): 2.36 (s, 3H, Me); 6.45 (d,
J = 8.1 Hz, 1H); 7.11 (t, J = 7.7 Hz, 1H); 7.17 (t, J = 7.4 Hz, 1H); 7.24–7.28
(m, 1H); 7.33–7.41 (m, 2H); 7.47–7.54 (m, 5H); 7.73 (t, J = 7.44 Hz,
1H); 7.79 (d, J = 7.50 Hz, 2H); 8.07 (d, J = 8.4 Hz, 1H, 5-H); 8.14 (d,
J = 8.7 Hz, 8-H, 1H); 8.43 (d, J = 8.0 Hz, 2H, 2,6-H1Ph).
13C NMR (300 MHz, CDCl3, ı ppm): 14.57; 110.61; 114.79; 118.78;
120.37; 123.01; 123.35; 123.98; 125.08; 127.55; 128.31; 128.90;
128.98; 129.45; 130.76; 130.98; 131.51; 137.41; 139.76; 142.02;
150.62; 152.57; 153.59; 156.00.
2.1.1. Pyrazolo[3,4-b]quinoline 6a–e: general procedure
Pyrazoloquinoline 5 (0.01 mol) and appropriate ArOH deriva-
tive (0.015 mol) were boiled in EtOH (50 mL) with KOH (0.015 mol).